SOLID LIPID NANOPARTICAL IN CORPORATED CREAM OF CLOBETASOL-17-PROPIONATE: DEVELOPMENT AND IN-VITRO EVALUATION

The clinical efficacy of glucocorticoids is dependent on its potency and on its ability to be absorbed in to the skin and therefore, reach its site of action. Colloidal drug carriers such as solid lipid nanoparticles could target glucocorticoids to the epidermis, where the anti-inflammatory action takes place. Topical corticosteroids have long been the chronic stage in the treatment of steroid responsive dermatitis. Creams containing Clobetasol-17-propionate (CP) as active ingredients are categorized as super potent class I topical dermatological corticosteroids. For the drug molecule to reach the cutaneous microcirculation, enhance, the systemic circulation, have to transverse both the lipophilic stratum cornium and much more viable epidermis. Various formulations of solid lipid nanoparticles were formulated using various ingridients viz. Compritol 888 ATO, lutrol F68, tween 80 etc. the cream formulations were evaluated as there pH, drug content, viscosity, spreadability, extrudability and percent drug release. In-vitro diffusion study using cellophane membrane as well as rat skin mounted in Franz diffusion cell. CP was analyzed spectrophotometrically at 240 nm.